Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Eléments de l'association

Berengere Debilly1
Antiparkinson Agents (therapeutic use)53
Berengere Debilly Sauf Antiparkinson Agents (therapeutic use)" 0
Antiparkinson Agents (therapeutic use) Sauf Berengere Debilly" 52
Berengere Debilly Et Antiparkinson Agents (therapeutic use) 1
Berengere Debilly Ou Antiparkinson Agents (therapeutic use) 53
Corpus679
\n\n\n\n \n

List of bibliographic references

Number of relevant bibliographic references: 1.
Ident.Authors (with country if any)Title
000424 Jan C. M. Zijlmans [Royaume-Uni, Pays-Bas] ; Berengere Debilly [France] ; Olivier Rascol [France] ; Andrew Lees (neurologue) [Royaume-Uni] ; Franck Durif [France]Safety of entacapone and apomorphine coadministration in levodopa‐treated Parkinson's disease patients: Pharmacokinetic and pharmacodynamic results of a multicenter, double‐blind, placebo‐controlled, cross‐over study

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024